We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Double-checking that a Form 483 is factually correct — and that the observations make sense — are two of the most important things a firm can do when given the document, said inspection expert David Chesney, principal of DL Chesney Consulting, in a recent WCG FDAnews webinar. Read More
The FDA has told Fullerton, Calif.-based Synovo Production to cease manufacture of its hip cup replacement system because the company failed to notify the agency about significant changes to the product. Read More
Burlington, Mass.- based LeMaitre Vascular drew a lengthy Form 483 from the FDA for failing to follow the company’s own corrective and preventive action (CAPA) procedure and to control nonconforming product, among other lapses.
The FDA has issued a warning letter to Tokyo-based endoscope manufacturer Olympus Medical Systems for failing to establish procedures to implement corrective and preventative actions as well as a lack of process validation for product changes, among other lapses.
North Carolina-based Carolina Biological Supply was handed a Form 483 for lacking adequate procedures for corrective and preventative actions (CAPA), medical device reporting (MDR) and audits, among other lapses.
Having operational logistics in place for your FDA inspection means writing down the inspection plan beforehand in a standard operating procedure (SOP), starting with the moment the investigators walk in the door, advised inspection expert David Chesney, principal of DL Chesney Consulting, in a recent WCG FDAnews webinar.
The FDA handed Oak Ridge Products a Form 483 for a lack of design control documents as well as inadequate corrective and preventive action (CAPA) procedures and complaint handling, among other lapses.
Alfa Wassermann, a West Caldwell, N.J.-based provider of chemistry analyzers, was handed a Form 483 for device history record (DHR) issues, lack of proper procedures for use and removal of manufacturing materials, and other lapses following a September 2022 inspection by the FDA.
Dominion Aesthetics Technologies, maker of Eon, a fat-reducing laser device, received a Form 483 following a September 2022 inspection of its Winter Park, Fla., facility for failure to properly handle complaints, to establish procedures for corrective and preventive action (CAPA) and to follow procedure for design control, among other lapses.
Be sure you understand the investigator’s questions during an FDA inspection – and always ask for clarification if you are unclear, advised inspection expert David Chesney, principal of DL Chesney Consulting, in a recent WCG FDAnews webinar.
Missouri-based Hi-Dow International, a manufacturer of transcutaneous nerve stimulators (TENS) units, received a form 483 for several repeat observations of failure to establish proper complaint procedures, lack of design controls, and inadequate procedures for corrective and preventive actions, among other lapses.
Texas-based Dalton Medical, a manufacturer of powered wheelchairs, adjustable hospital beds and other durable medical equipment, received a Form 483 for failure to establish design control and complaint handling procedures, among other lapses.